5 Health Services Stocks On The Rise

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 56 points (-0.3%) at 15,939 as of Wednesday, Feb. 12, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,598 issues advancing vs. 1,323 declining with 154 unchanged.

The Health Services industry currently sits up 0.3% versus the S&P 500, which is down 0.1%. Top gainers within the industry include Mine Safety Appliances ( MSA), up 5.8%, Catamaran ( CTRX), up 3.0%, Fresenius Medical Care AG & Co. KGaA ( FMS), up 1.2% and Smith & Nephew ( SNN), up 0.7%. A company within the industry that fell today was Mettler-Toledo International ( MTD), up 1.4%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. DaVita HealthCare Partners ( DVA) is one of the companies pushing the Health Services industry higher today. As of noon trading, DaVita HealthCare Partners is up $3.50 (5.4%) to $67.83 on heavy volume. Thus far, 2.1 million shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $66.80-$68.84 after having opened the day at $67.93 as compared to the previous trading day's close of $64.33.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $13.6 billion and is part of the health care sector. Shares are up 1.5% year-to-date as of the close of trading on Tuesday. Currently there are 9 analysts who rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full DaVita HealthCare Partners Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

4. As of noon trading, Covidien ( COV) is up $0.53 (0.8%) to $70.44 on light volume. Thus far, 690,272 shares of Covidien exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $69.67-$70.65 after having opened the day at $69.67 as compared to the previous trading day's close of $69.91.

Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. Covidien has a market cap of $31.1 billion and is part of the health care sector. Shares are up 2.7% year-to-date as of the close of trading on Tuesday. Currently there are 14 analysts who rate Covidien a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Covidien as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Covidien Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

3. As of noon trading, Boston Scientific ( BSX) is up $0.10 (0.7%) to $12.94 on light volume. Thus far, 3.4 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 11.9 million shares. The stock has ranged in price between $12.83-$12.99 after having opened the day at $12.83 as compared to the previous trading day's close of $12.85.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $17.2 billion and is part of the health care sector. Shares are up 6.9% year-to-date as of the close of trading on Tuesday. Currently there are 8 analysts who rate Boston Scientific a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Boston Scientific as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet. Get the full Boston Scientific Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, St Jude Medical ( STJ) is up $0.82 (1.3%) to $64.85 on light volume. Thus far, 951,111 shares of St Jude Medical exchanged hands as compared to its average daily volume of 2.6 million shares. The stock has ranged in price between $64.11-$65.02 after having opened the day at $64.17 as compared to the previous trading day's close of $64.03.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems. St Jude Medical has a market cap of $18.6 billion and is part of the health care sector. Shares are up 3.4% year-to-date as of the close of trading on Tuesday. Currently there are 13 analysts who rate St Jude Medical a buy, 1 analyst rates it a sell, and 8 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full St Jude Medical Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Intuitive Surgical ( ISRG) is up $6.56 (1.5%) to $433.00 on light volume. Thus far, 153,881 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 524,600 shares. The stock has ranged in price between $427.20-$433.69 after having opened the day at $428.73 as compared to the previous trading day's close of $426.45.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $16.4 billion and is part of the health care sector. Shares are up 11.0% year-to-date as of the close of trading on Tuesday. Currently there are 8 analysts who rate Intuitive Surgical a buy, 4 analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, notable return on equity, good cash flow from operations, expanding profit margins and growth in earnings per share. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Intuitive Surgical Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

UnitedHealth Shares Jump on Fourth-Quarter Earnings Beat, Improved Guidance

UnitedHealth Shares Jump on Fourth-Quarter Earnings Beat, Improved Guidance

Are You Ready For a Correction?

Are You Ready For a Correction?

Aetna CEO to Receive $500 Million Once CVS Deal Closes: MARKETS LIVE

Aetna CEO to Receive $500 Million Once CVS Deal Closes: MARKETS LIVE

Dow and S&P 500 Decline, but Nasdaq Finishes Higher as Tech Recovers

Dow and S&P 500 Decline, but Nasdaq Finishes Higher as Tech Recovers

3 Things You Must Know About Wall Street as You Head to Lunch

3 Things You Must Know About Wall Street as You Head to Lunch